Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG36260

KCNK3 Knockout KYSE150 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Esophagus

  • Disease:

    Squamous cell carcinoma

The KCNK3 Knockout KYSE-150 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population with targeted disruption of KCNK3, encoding the pH- and hypoxia-sensitive TASK-1 potassium channel. Derived from the human esophageal squamous cell carcinoma line KYSE-150, these cells enable loss-of-function studies in a cancer-relevant background. TASK-1 regulates resting membrane potential and is modulated by GPCR signals through PKC and by cellular stressors. Its inhibition leads to membrane depolarization and calcium influx. Applications include electrophysiology, calcium imaging, and cancer cell phenotype assays, supporting research in pulmonary hypertension and esophageal cancer biology.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    KYSE-150

    Sex of Donor

    Female

    Age

    49 years

    Gene Name

    KCNK3

    Gene Identifier

    NCBI Gene ID 3777

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640:Ham's F-12(1:1)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KCNK3 Knockout KYSE-150 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population derived from the human esophageal squamous cell carcinoma line KYSE-150, carrying targeted disruption of the KCNK3 gene. This gene encodes TASK-1, a two-pore domain potassium channel that mediates background potassium currents critical for setting the resting membrane potential. The polyclonal knockout pool provides a heterogeneous loss-of-function model, enabling the study of TASK-1-dependent physiology without clonal selection.

KYSE-150 is a widely used epithelial cell line established from a well-differentiated esophageal squamous cell carcinoma of a Japanese patient. It serves as a robust model for cancer biology research, including investigations into tumorigenesis, drug sensitivity, and signal transduction pathways relevant to esophageal cancer. The cells maintain characteristic features of squamous epithelial origin and are frequently employed in studies of oncogenic drivers, chemoresistance, and the tumor microenvironment.

KCNK3 (TASK-1) channels are inhibited by acidosis, hypoxia, volatile anesthetics, and Gq-coupled receptor signaling. Upon Gq activation, phospholipase C generates diacylglycerol, which stimulates protein kinase C to phosphorylate and inhibit TASK-1, causing membrane depolarization. Protein kinase A also modulates channel activity. The resulting depolarization opens voltage-gated calcium channels, triggering calcium influx that influences downstream targets such as cell proliferation and apoptosis. TASK-1 interacts with 14-3-3 proteins and can form heterodimers with TASK-3 (KCNK9), adding to the complexity of its regulation.

In the esophageal squamous cell carcinoma context, the tumor microenvironment is often acidic and hypoxic??conditions that modulate TASK-1 activity. Knockout of KCNK3 in KYSE-150 cells enables dissection of how TASK-1-dependent membrane potential changes affect calcium signaling, cell proliferation, migration, and invasion. This model thus provides a platform to evaluate the contribution of this potassium channel to ESCC pathobiology, including potential roles in pH sensing and adaptation to metabolic stress.

Applications of this polyclonal knockout model include patch-clamp electrophysiology to assay potassium currents, fluorescence-based membrane potential and calcium imaging, cell proliferation and migration/invasion assays, and western blotting for target validation. The cells are also suitable for compound screening against TASK-1 and for investigating pH-sensing mechanisms in cancer. Transcriptomic analysis via RNA-seq can uncover pathways affected by KCNK3 disruption. For further details or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)